SprintRay's Midas Restore Is an FDA-Cleared Ceramic Dental Resin

What Midas Restore Is

SprintRay is selling Midas Restore, a glass ceramic and zirconia-filled resin meant for definitive dental restorations: crowns, inlays, onlays, and single veneers. The U.S. Food and Drug Administration cleared it for chairside use, and the material is available now in the United States with European Union availability starting October 1, 2026.

Why the Filler Content Matters

Most dental resins max out around 50% to 60% filler by weight because viscosity becomes a problem on conventional vat polymerization printers. Midas Restore pushes past that at more than 75% filler. SprintRay says it achieved this by pairing the formulation with its Midas Digital Press, which uses a capsule-based system instead of a traditional vat and build platform. That removes the viscosity limit.

What It Means for Patients and Dentists

The practical benefit is a same-visit restoration. A patient can walk in with a cavity or damaged tooth and leave with a permanent crown or veneer printed on-site. SprintRay positioned the material around how it behaves once bonded to tooth structure rather than around a single strength number. The company says the resin offers wear resistance comparable to a milled hybrid ceramic, hardness on par with a leading direct composite, and enamel-like translucency.

How It Fits the Market

Dental labs have been using 3D printing for years, mostly for temporary restorations, surgical guides, and models. Midas Restore is aimed at the final, permanent restoration step, which is a harder sell because it has to survive years of chewing. SprintRay is not the only company chasing this space, but the 75% filler claim and FDA clearance give it a concrete differentiator in a market where many materials are still pending regulatory approval.